Edward Conaway v. Ernest Uzicanin, Janette Clark, Holly Hoover, and NBCI

CourtDistrict Court, D. Maryland
DecidedFebruary 25, 2026
Docket1:25-cv-00193
StatusUnknown

This text of Edward Conaway v. Ernest Uzicanin, Janette Clark, Holly Hoover, and NBCI (Edward Conaway v. Ernest Uzicanin, Janette Clark, Holly Hoover, and NBCI) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Edward Conaway v. Ernest Uzicanin, Janette Clark, Holly Hoover, and NBCI, (D. Md. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

EDWARD CONAWAY,

Plaintiff, Civil Action No. 25-193-BAH

v.

ERNEST UZICANN ET AL.,

Defendants.

MEMORANDUM OPINION

Self-represented Plaintiff Edward Conaway (“Conaway”), who is currently incarcerated at North Branch Correctional Institution (“NBCI”) in Cumberland, Maryland, filed this civil rights complaint pursuant to 42 U.S.C. § 1983, against Defendants Ernest Uzicanin (“Dr. Uzicanin”), Janette Clark (“Clark”), Holly Hoover (“Hoover”), and NBCI alleging that Defendants failed to provide him adequate medical care. ECF 11. Currently pending are Dr. Uzicanin’s1 Motion to Dismiss or, in the Alternative, Motion for Summary Judgement, ECF 22 (motion); ECF 26 (corrected memorandum), Conaway’s Argument Motion (ECF 27), Clark and Hoover’s Motion to Dismiss or, Alternatively, for Summary Judgment (ECF 34), and Conaway’s Motion for Subpoena Duces Tecum (ECF 38). Both dispositive motions are fully briefed and ripe for review.2 No

1 The Clerk will be directed to amend the docket to reflect the correct spelling of Defendant Dr. Uzicanin’s name.

2 The Court construes Conaway’s Argument Motion (ECF 27) as an opposition and it will be considered with Dr. Uzicanin’s motion, but will be denied insofar as it seeks oral argument on the motion. Similarly, Conaway’s Motion for Subpoena Duces Tecum (ECF 38) does not request the issuance of a subpoena and is denied in that respect, but is nonetheless considered as an opposition as Conaway presents additional reasons why the Court should rule in his favor with respect to Clark and Hoover’s motion. The Court will also consider the three “declarations” filed by hearing is necessary. See Loc. R. 105.6 (D. Md. 2025). For the reasons stated below, Defendants’ motions, ECFs 22 and 34, both construed as motions for summary judgment, will be GRANTED. I. BACKGROUND A. Allegations

Conaway asserts that due to Defendants’ failure to provide adequate medical care he suffers from fever, chills, and stomach pain following a Urinary Tract Infection (“UTI”). ECF 11, at 4. He claims that his UTI was untreated for two years while incarcerated at NBCI and Western Correctional Institution (“WCI”) and he was denied outside treatment or “stronger” pain medications. Id. Specifically, he claims Defendant Clark refused any treatment for his UTI on February 6, 2022, at WCI; Defendant Hoover refused him medication during a sick call on April 12, 2024, at NBCI; and Dr. Uzicanin denied him “stronger medications” for his UTI on March 3, 2024. Id. Conaway attaches to his Amended Complaint a Request for Administrative Remedy (also known as an “ARP”) in which he asserts that he was still sick and that Dr. Uzicanin had promised Conaway would go to the WCI infirmary for IV medications, but Conaway alleges he

was never taken for IV medications. ECF 11-2 at 6. Conaway also attaches an ARP saying that despite taking “micro bid 100mgs,” his UTI persisted. Id. at 12. In his supplement to the Amended Complaint, Conaway explains further that he was prescribed “cipro” but that it was not strong enough to cure his UTI. ECF 13 at 1. B. Medical Records and Declarations Dr. Uzicanin attests that Conaway is highly susceptible to UTIs because of the chronic suprapubic catheter implanted after he suffered a penile avulsion from a 2006 car accident. ECF

Conaway, and attachments thereto. ECF 29 (declaration filed on 7/11/25); ECF 36 (declaration filed on 9/2/25); ECF 37 (declaration filed on 9/8/25). 22-5, at ¶ 5; see ECF 34-3, at 11–12. Since 2022, Conaway’s chronic UTIs have been treated with oral and intravenous medications, and he has also been evaluated by both urology and infectious disease specialists. ECF 22-5, at ¶ 4, 6. Hoover, a certified registered nurse practitioner, attests that because Conaway has an indwelling catheter, there will always be bacteria in his urine. ECF

34-2, at ¶ 5. The catheter is changed regularly to minimize the bacteria, but Hoover notes that Conaway has a history of refusing catheter changes. Id. According to infectious disease specialists, in order to avoid antibiotic resistance, Conaway only needs antibiotics for UTIs if he is symptomatic. Id. Conaway’s alleged refusals of care contribute to the frequency and severity of his UTIs. Id. at ¶ 24. As of December 13, 2023, Conaway’s catheter was being changed every four weeks. ECF 34-3, at 7. Conaway reported to Dr. Nilesh Tejura, an infectious disease specialist, that his UTIs were recurring, most recently in August of 2023, and that he was experiencing suprapubic pain and had dark sedimentation in his urine. Id. Dr. Tejura noted that a urine culture on November 30, 2023, grew K. pneumoniae, a multi-drug-resistant (“MDR”) bacteria, resulting in Conaway’s

admission to the infirmary. Id. Conaway received three doses of piperacillin-tazobactam on December 7, 2023, and then received Fosfomycin, the only active oral antimicrobial agent effective for K. pneumoniae. Id. at 7, 9. Dr. Tejura ordered completion of the Fosfomycin course, exchange of Conaway’s catheter to avoid a recurrent infection, and a follow-up appointment in two weeks. Id. at 9. Conaway returned for a provider visit on December 20, 2023 with Dr. Dhimitri Gross. ECF 34-3, at 2–6. Conaway reported that his pain was being managed by the prescribed medications but that his UTI had not yet been fully resolved. Id. at 2. Conaway stated that he still needed to receive two doses of Fosfomycin. Id. Dr. Gross ordered that he receive these additional doses and that a “urinalysis with reflex to culture” be conducted to confirm that the UTI was completely resolved. Id. at 4–5. According to custody staff, on January 10, 2024, Conaway did not appear for a telemedicine visit with Dr. Tejura because he refused to attend the appointment. ECF 34-5 at 17. Conaway’s Lyrica prescription for pain was also discontinued in January for non-

compliance. Id. at 16. Dr. Gross saw Conaway again in the chronic care clinic on January 24, 2024. ECF 34-5, at 11–15. Conaway had received all Fosfomycin doses but reported that his symptoms were flaring up. Id. at 11. Conaway also complained that he had not seen a urologist since he was housed at Western Correctional Institution more than two years prior. Id. Dr. Gross assessed an ongoing UTI and prescribed another round of Fosfomycin to treat it. Id. at 14. He also submitted a consultation request for Conaway to be seen at University of Maryland Medical System (“UMMS”) Urology, which was approved and scheduled for May 21, 2024. Id. at 7–10, 14, 32– 33. Dr. Gross entered an administrative note on January 31, 2024 attesting that Conaway’s urine culture contained K. pneumoniae yet again. Id. at 6. An infectious disease provider recommended

IV meropenem to Dr. Gross based on Conaway’s history, a treatment which would require admission to the infirmary. Id. Conaway initially refused the IV antibiotics but after an appointment on February 8, 2024 with Dr. Gross, he agreed to a seven-day course. Id. at 1-5, 21; ECF 34-4, at 33-34. Beverly McLaughlin, a nurse practitioner, saw Conaway on February 11, 2024, his fourth day in the infirmary. ECF 34-4, at 30–31. Conaway complained to McLaughlin that the staff was harassing him and his IV had been left in overnight. Id. at 31. McLaughlin notes that Conaway became agitated during the conversation, called her “dumb,” and threatened to have his sister beat her up. Id. McLaughin and the other staff present exited the room with Conaway’s IV pole, and McLaughlin later opined that Conaway’s admission to the infirmary may have exacerbated any mental illness he was experiencing. Id. Conaway, who eventually reported improvement, was discharged back to NBCI. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United Mine Workers of America v. Gibbs
383 U.S. 715 (Supreme Court, 1966)
Gregg v. Georgia
428 U.S. 153 (Supreme Court, 1976)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Carnegie-Mellon University v. Cohill
484 U.S. 343 (Supreme Court, 1988)
Wilson v. Seiter
501 U.S. 294 (Supreme Court, 1991)
Hudson v. McMillian
503 U.S. 1 (Supreme Court, 1992)
Hope v. Pelzer
536 U.S. 730 (Supreme Court, 2002)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
United States v. Clawson
650 F.3d 530 (Fourth Circuit, 2011)
Henry v. Purnell
652 F.3d 524 (Fourth Circuit, 2011)
Dulaney v. Packaging Corp. of America
673 F.3d 323 (Fourth Circuit, 2012)
Parrish v. Cleveland
372 F.3d 294 (Fourth Circuit, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Edward Conaway v. Ernest Uzicanin, Janette Clark, Holly Hoover, and NBCI, Counsel Stack Legal Research, https://law.counselstack.com/opinion/edward-conaway-v-ernest-uzicanin-janette-clark-holly-hoover-and-nbci-mdd-2026.